OraSure Technologies (OSUR)

Company

"OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices." (company website)

osur(1-1)
OSUR 4-month chart
osur(1-1)_1yr
OSUR 1-year chart
osur(1-1)_p&f OSUR point & figure chart

Buy

25 March 2010. Bought 500 at $6.00.

OSUR delivered an earnings Surprise in February that propelled it back above the previous resistance level around $5.50. After a new peak it retreated to the 50-day average and is now breaking above the last peak. The point & figure chart shows OSUR building a new column of Xs after a triple-top breakout in December.

  • Percentage price oscillator (PPO) — crossed back above the signal line after the stock touched back with the 50-day moving average
  • Volume — several above-normal up-days with few above-normal down-days

Based on technical analysis, MarketEdge calls OSUR a "hold" and notes "mildly deteriorating conditions" and that it is above resistance ($5.58) and is "overbought."

Sell

gain Bottom line
0%

7 April 2010. Sold 500 at $6.06.

If Orasure is going to break above its current level, it's keeping it a well-hidden secret. Volumes have trickled off and momentum has slowed. I'm thinking it might actually pull back again before/if it advances farther.